RxSight (RXST) Releases Q4 2025 Earnings: Revenue Down but Beats Estimates; Loss Narrows, EPS Beats

RxSight Inc. (RXST) reported Q4 2025 results.

Revenue: $32.6 million (down 18.9% year-over-year), above the estimate of $30.7 million.

Gross profit: $25.3 million (down 12.2% year-over-year).

Operating loss: $12.2 million (loss narrowed 41.2% year-over-year).

Net loss attributable to common shareholders: $9.8 million (loss narrowed 65.3% year-over-year).

Diluted loss per share: -0.22 (improved 46.7% year-over-year; estimate -0.339).

Operating cash flow: used $1.2 million (down 72.1% year-over-year).

Capital spending: $0.6 million (down 31.4% year-over-year).

Cash and cash equivalents: $19.9 million (up 19.4% year-over-year).

Total liabilities: $36.1 million (down 3.2% year-over-year).

Overall, RxSight (RXST) beat revenue and EPS expectations, reported narrower operating and net losses, and closed the quarter with approximately $19.9 million in cash while keeping liabilities slightly lower year-over-year.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

RxSight Inc. Hedge Fund Activity

We have seen 90 institutional investors add shares of RxSight Inc. stock to their portfolio, and 121 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

RA CAPITAL MANAGEMENT, L.P. removed 3,702,967 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $33,289,673
NOMURA HOLDINGS INC added 2,000,060 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,840,625
POINT72 ASSET MANAGEMENT, L.P. added 1,075,563 shares (+692.6%) to their portfolio in Q4 2025, for an estimated $11,207,366
CREDIT AGRICOLE S A removed 786,063 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,066,706
WELLINGTON MANAGEMENT GROUP LLP removed 727,952 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,544,288
4D ADVISORS, LLC removed 554,930 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,782,370
ROYAL BANK OF CANADA removed 475,102 shares (-96.1%) from their portfolio in Q4 2025, for an estimated $4,950,562

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RxSight Inc. Analyst Ratings

Wall Street analysts have issued reports on $RXST in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Underweight" rating on 11/06/2025
Needham issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for RxSight Inc., check out Quiver Quantitative's $RXST forecast page.

RxSight Inc. Price Targets

Multiple analysts have issued price targets for $RXST recently. We have seen 5 analysts offer price targets for $RXST in the last 6 months, with a median target of $10.0.

Here are some recent targets:

Adam Maeder from Piper Sandler set a target price of $11.0 on 01/20/2026
Patrick Wood from Morgan Stanley set a target price of $10.0 on 12/02/2025
Robbie Marcus from JP Morgan set a target price of $9.0 on 11/06/2025
David Saxon from Needham set a target price of $12.0 on 11/06/2025
Larry Biegelsen from Wells Fargo set a target price of $10.0 on 11/06/2025